Medicare Enrolled

Dr. Howard Rubin, M.D.

Cardiovascular Disease · Houston, TX
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
5115 FANNIN ST STE 801, Houston, TX 77004
7137900841
In practice since 2005 (20 years)
NPI: 1295734432 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rubin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rubin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rubin

Dr. Howard Rubin is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Rubin performed 5,760 Medicare services across 3,327 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rubin received a total of $7,265 from 33 pharmaceutical and/or device companies across 337 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rubin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 12% volume in TX$ $7,265 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,760
Medicare services
Top 12% in TX for cardiovascular disease
3,327
Unique beneficiaries
$144
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~288 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test1,130$43$119
Office visit, established patient (20-29 min)570$71$110
Electrocardiogram (EKG), 12-lead555$10$125
Echocardiogram, transthoracic544$141$1,404
Office visit, established patient (30-39 min)327$89$145
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician308$52$575
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries260$623$1,988
Chronic care management, first 20 min/month226$46$120
Ultrasound of both sides of head and neck blood flow218$148$658
Nuclear medicine studies of blood flow in heart muscle at rest and with stress215$1,061$3,250
Remote patient monitoring device, 30 days179$40$128
Remote patient monitoring management, 20 min/month160$39$128
Remote pacemaker monitoring, 90 days155$23$94
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days116$20$110
Chronic care management, additional 20 min/month110$36$118
Injection, sulfur hexafluoride lipid microspheres, per ml110$12$30
Hospital follow-up visit, moderate complexity73$63$150
Hospital follow-up visit, high complexity54$92$175
Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment51$15$49
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan44$1,937$6,033
Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days37$197$669
Ultrasound study of arm or leg veins with compression and maneuvers37$147$503
Ultrasound of leg arteries or artery grafts33$183$800
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional32$15$65
New patient office visit (45-59 min)31$127$396
Technetium tc-99m tetrofosmin, diagnostic, per study dose31$69$484
Nuclear medicine studies of heart muscle at rest and with stress and spect30$352$2,115
Office visit, established patient, complex (40-54 min)28$112$215
Ultrasound study of arm and leg arteries18$53$380
Initial hospital admission, high complexity18$140$300
Complete ultrasound of abdomen and pelvis artery and vein blood flow17$209$955
Evaluation of single, dual, multiple lead or leadless pacemaker system16$31$110
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional14$678$2,345
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts13$124$445
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.6% high complexity
37.5% medium
49.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,265
Total received (2018-2024)
Avg $1,038/year across 7 years
Top 39% in TX for cardiovascular disease
33
Companies
337
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,245 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$19 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,151
2023
$1,344
2022
$1,514
2021
$947
2020
$334
2019
$487
2018
$489

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$1,310
E.R. Squibb & Sons, L.L.C.
$927
Amgen Inc.
$766
PFIZER INC.
$712
Novartis Pharmaceuticals Corporation
$488
Janssen Pharmaceuticals, Inc
$470
AstraZeneca Pharmaceuticals LP
$374
Medtronic, Inc.
$287
Boston Scientific Corporation
$246
BIOTRONIK INC.
$182
Novo Nordisk Inc
$172
Edwards Lifesciences Corporation
$156
Acutus Medical, Inc.
$135
HeartFlow, Inc.
$119
SANOFI-AVENTIS U.S. LLC
$117
Merck Sharp & Dohme LLC
$116
Boehringer Ingelheim Pharmaceuticals, Inc.
$95
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$78
Tactile Systems Technology Inc
$60
Esperion Therapeutics, Inc.
$52
SCPHARMACEUTICALS INC.
$51
Bayer HealthCare Pharmaceuticals Inc.
$49
Lexicon Pharmaceuticals, Inc.
$47
Regeneron Healthcare Solutions, Inc.
$41
Astellas Pharma US Inc
$41
Merz North America, Inc.
$37
Amarin Pharma Inc.
$31
Impulse Dynamics (USA) Inc.
$24
Kiniksa Pharmaceuticals International, plc
$22
iRhythm Technologies, Inc.
$17
Biosense Webster, Inc.
$16
Gilead Sciences, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$14
Top 3 companies account for 41.3% of total payments
Associated products mentioned in payments ›
ACCOLADE SR · Adempas · Arcalyst · CAMZYOS · CARDIOMEMS · CARTO 3 · CHANTIX · CardioMEMS HF System · CareLink · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edora · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · Flexitouch Plus · HAWKONE · HeartMate 3 Left Ventricular Assist Device · INVOKANA · Inpefa · JARDIANCE · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · NEXLETOL · ONYX FRONTIER · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · Perclose ProGlide suture mediated closure system · Repatha · SAPIEN 3 Ultra RESILIA · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · Ultreon · VERQUVO · VYNDAQEL · Vascepa · Verquvo · WAINUA · WATCHMAN · WATCHMAN FLX · XARELTO · XEOMIN · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $126 per 100 Medicare services performed
Looking for a cardiovascular disease in Houston?
Compare cardiovascular diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
396
Per 100K population
8.3
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rubin is a cardiac imaging specialist, with above-average Medicare volume (top 12% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rubin experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Rubin performed 1,130 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rubin receive payments from pharmaceutical companies?
Yes. Dr. Rubin received a total of $7,265 from 33 companies across 337 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rubin's costs compare to other cardiovascular diseases in Houston?
Dr. Rubin's average Medicare payment per service is $144. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rubin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →